Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1710
    +0.0016 (+0.14%)
     
  • GBP/USD

    1.2624
    +0.0002 (+0.01%)
     
  • Bitcoin GBP

    55,845.62
    +664.14 (+1.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,343.84
    +175.77 (+0.44%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

Activist Bluebell builds stake in Bayer, pushes for company breakup -Bloomberg

FILE PHOTO: Logo of Bayer AG at a plant of the German pharmaceutical and chemical maker in Wuppertal

(Reuters) -Activist investor Bluebell Capital Partners has built a stake in Bayer AG and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg reported on Tuesday, citing sources.

UK-based Bluebell is also seeking an overhaul of Bayer's corporate governance, the report added.

A Bayer spokesperson, who declined to comment on the report, said: "Generally speaking we are always open for a constructive dialogue with our stakeholders."

Bluebell didn't immediately respond to a request seeking comment.

The report follows news on Monday that the activist investment fund Inclusive Capital Partners, run by hedge fund veteran Jeffrey Ubben, had acquired a 0.83% stake in Bayer, which continues to suffer from a weak market value.

Bloomberg said the size of the Bluebell holding was undisclosed.

(Reporting by Shivani Tanna in Bengaluru; Additional reporting by Tom Sims in Frankfurt; Editing by Jane Merriman and Cynthia Osterman)